Zynerba Pharmaceuticals Story
| ZYNEDelisted Stock | USD 1.30 0.04 3.17% |
About 55% of Zynerba Pharmaceuticals' shareholders are presently thinking to get in. The analysis of current outlook of investing in Zynerba Pharmaceuticals suggests that some traders are interested regarding Zynerba Pharmaceuticals' prospects. Zynerba Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Zynerba Pharmaceuticals. The current market sentiment, together with Zynerba Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Zynerba Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Zynerba Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Zynerba daily returns and investor perception about the current price of Zynerba Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Zynerba |
Requested story not found. it has been either deleted or moved. View all stories for Zynerba Pharmaceuticals.
Zynerba Pharmaceuticals Latest Timeline
Zynerba Pharmaceuticals is listed for 1.30. The company has Price to Book (P/B) ratio of 0.54. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Zynerba Pharmaceuticals recorded a loss per share of 0.8. The entity had not issued any dividends in recent years.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Zynerba Stock
If you are still planning to invest in Zynerba Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zynerba Pharmaceuticals' history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |